With changes in demographics and advancements in cancer care, the current oncologist workforce is expected to experience an ...

Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer ...

Two scientists and an editor spent six months investigating so-called paper mills, which churn out bogus scientific papers ...

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ovarian tumors and possibly other types of cancer.

The test can be used to better stratify cancer patients and determine the likelihood of breast cancer metastasizing.

Tess, 33, who goes by the name @thegreenthumbmum said she now wants other women to take the symptoms seriously and insisted ...

As a breast cancer survivor, I feel it is incumbent upon me to give an accurate picture of cancer to others, particularly ...

A new precision oncology paper was published in , Volume 16, on March 12, 2025, titled "Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation ...

A new research paper was published by Aging (Aging-US) on March 7, 2025, titled "Accelerated aging associated with cancer characteristics and treatments among breast cancer survivors." ...

If I thought there was a problem, I would have stated it in the paper,” Joseph Borzelleca, 94, a professor emeritus of ...

A cancer drug developed ten years ago at UCSF can also put the brakes on one of prostate cancer's deadliest molecular tricks.

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...